XNDU SEC Filings, Earnings & Splits

OMERS Administration Corporation filed an amended Schedule 13G reporting it now beneficially owns 36,613,907 Class B Subordinate Voting Shares (18.7%) of Xanadu Quantum Technologies, after converting 39,746,515 Class A Multiple Voting Shares into SVS and selling 3,632,608 SVS between July and September 2026.

Xanadu Quantum Technologies filed a prospectus supplement (424B3) updating its F-1 registration statement with its Q3 2026 results via Form 6-K, reporting continued loss-reduction progress, new manufacturing partnerships (ASML, Bluefors, GlobalFoundries), and government funding support.

Xanadu Quantum Technologies filed a 424B3 prospectus supplement attaching its Form 6-K containing Q3 2026 financial results and business updates, including manufacturing partnerships with ASML, Bluefors, and GlobalFoundries, and the launch of Backline with AMD.

Xanadu Quantum Technologies filed its Q3 2026 quarterly report on Form 6-K, which includes a restatement adjustment to previously reported shareholders' equity figures for fiscal years 2024 and 2025. The filing reflects the conversion of Old Xanadu convertible preferred shares and common stock into new Class A and Class B common stock, along with warrant exercises.

Xanadu Quantum Technologies received provisional approval for up to USD $10 million in additional DARPA funding under the Quantum Benchmarking Initiative, a one-year contract extension supporting its photonic quantum computing R&D roadmap.

Xanadu Quantum Technologies received provisional approval for up to USD $10 million in additional DARPA funding under the Quantum Benchmarking Initiative, a one-year contract extension building on its Stage B work. The company will use the majority of the funding to accelerate its photonic quantum computing R&D roadmap.

Xanadu Quantum Technologies announced it has secured up to USD $10 million in additional DARPA support to accelerate its quantum R&D roadmap.

An institutional holder filed an amended Schedule 13G indicating a change in its passive ownership stake in Xanadu Quantum Technologies Ltd. The filing text available is only the EDGAR directory listing, so specific ownership details are not disclosed.

An amendment to a Schedule 13D was filed regarding Xanadu Quantum Technologies Ltd, indicating a change in a previously reported beneficial ownership position. The filing text provided contains only the EDGAR directory listing and no substantive details of the amendment.